Physician profile
Robert E Ranney
NPI 1902807670
$4,299.83
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,447 · 2020: $565 · 2021: $12.96 · 2023: $18.75 · 2024: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $829.89 | 2019-2020 | |
| Pfizer INC. | $440.16 | 2019-2020 | |
| Amgen INC. | $427.49 | 2019-2020 | |
| Glaxosmithkline, LLC. | $352.91 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $348.17 | 2019-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $323.93 | 2019-2024 | |
| Lilly USA, LLC | $222.63 | 2019-2024 | Zepbound, Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.57 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $159.58 | 2019-2020 | |
| Allergan, INC. | $123.39 | 2019-2020 | |
| Astellas Pharma US INC | $101.49 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.30 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $75.36 | 2019-2020 | |
| Amarin Pharma, INC. | $65.84 | 2019-2020 | |
| Radius Health, INC. | $64.83 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $63.90 | 2019 | |
| Kaleo, INC. | $58.46 | 2019-2020 | |
| Abbvie INC. | $46.90 | 2019 | |
| Therapeuticsmd, INC. | $40.20 | 2019 | |
| Sanofi Pasteur INC. | $37.34 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.41 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $26.07 | 2019 | |
| Irhythm Technologies, INC. | $21.64 | 2019 | |
| Hologic Sales and Service, LLC | $21.20 | 2020 | |
| Bausch Health US, LLC | $20.91 | 2019 | |
| Avanir Pharmaceuticals, INC. | $20.59 | 2019 | |
| Dexcom, INC. | $20.32 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $19.88 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.78 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ranney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.